Oncology

Carcinoma of Unknown Primary: Improved Ways to Manage Patients

In cases of carcinoma of unknown primary (CUP), the initial goal is to identify the occult tumor so the patient can have the best oncologic outcome and minimize treatment-related side effects. A retrospective study showed that transoral robotic surgery (TORS) successfully detected the occult malignancy for 80 percent of patients. Many of these patients were subsequently able to forgo radiation (25 percent) and/or chemotherapy (67 percent).

In this white paper, Dr. Kyle Hatten, Assistant Professor of Otorhinolaryngology and Director of Robotic Surgery in the Department of Otorhinolaryngology at the University of Maryland School of Medicine, explains how TORS improves both the diagnosis and treatment of CUP.

Related Content

  •         Head and Neck Mucosal Primary Cancer Clinical Trial: 1685GCC: Phase II/III Randomized Trial of Intensity-Modulated Proton Beam Therapy (IMPT) versus Intensity-Modulated Photon Therapy (IMRT) for the Treatment of Oropharangeal Cancer of the Head and Neck

Related People

Kyle Hatten, MD.

Kyle Hatten, MD

Assistant Professor

Dr. Kyle Hatten is the Director of Robotic Surgery in the Department of Otorhinolaryngology – Head & Neck Surgery. He is a board certified by the American Board of Otolaryngology – Head and Neck Surgery. A graduate of the University ...

View full profile